UNLABELLED: In this report, the prevalence and multifactorial etiology of anemia among Indian human immunodeficiency virus (HIV)-infected children are described. HIV-infected children aged 2-12 years were prospectively enrolled in 2007-2008. Measured parameters included serum ferritin, vitamin B(12), red-cell folate, soluble transferrin receptor, and C-reactive protein. Children received antiretroviral therapy (ART), iron and, folate supplements as per standard of care. Among 80 enrolled HIV-infected children (mean age 6.8 years), the prevalence of anemia was 52.5%. Etiology of anemia was found to be iron deficiency alone in 38.1%, anemia of inflammation alone in 38.1%, combined iron deficiency and anemia of inflammation alone in 7.1%, vitamin B(12) deficiency in 7.1%, and others in 9.5%. Median iron intake was 5.7 mg/day (recommended dietary allowance 18-26 mg/day). Compared to nonanemic children, anemic children were more likely to be underweight (weight Z-score -2.5 vs. -1.9), stunted (height Z-score -2.6 vs. -1.9), with lower CD4 counts (18% vs. 24%, p < 0.01), and higher log viral load (11.1 vs. 7.1, p < 0.01). Hemoglobin (Hb) improved significantly among those who started ART (baseline Hb 11.6 g/dl, 6-month Hb 12.2 g/dl, p = 0.03). Children taking ART combined with iron supplements experienced a larger increase in Hb compared to those receiving neither ART nor iron supplements (mean Hb change 1.5 g/dl, p < 0.01). CONCLUSION: Anemia, particularly iron deficiency anemia and anemia of inflammation, is highly prevalent among children with HIV infection. Micronutrient supplements combined with ART improved anemia in HIV-infected children.
UNLABELLED: In this report, the prevalence and multifactorial etiology of anemia among Indian human immunodeficiency virus (HIV)-infectedchildren are described. HIV-infectedchildren aged 2-12 years were prospectively enrolled in 2007-2008. Measured parameters included serum ferritin, vitamin B(12), red-cell folate, soluble transferrin receptor, and C-reactive protein. Children received antiretroviral therapy (ART), iron and, folate supplements as per standard of care. Among 80 enrolled HIV-infectedchildren (mean age 6.8 years), the prevalence of anemia was 52.5%. Etiology of anemia was found to be iron deficiency alone in 38.1%, anemia of inflammation alone in 38.1%, combined iron deficiency and anemia of inflammation alone in 7.1%, vitamin B(12) deficiency in 7.1%, and others in 9.5%. Median iron intake was 5.7 mg/day (recommended dietary allowance 18-26 mg/day). Compared to nonanemic children, anemicchildren were more likely to be underweight (weight Z-score -2.5 vs. -1.9), stunted (height Z-score -2.6 vs. -1.9), with lower CD4 counts (18% vs. 24%, p < 0.01), and higher log viral load (11.1 vs. 7.1, p < 0.01). Hemoglobin (Hb) improved significantly among those who started ART (baseline Hb 11.6 g/dl, 6-month Hb 12.2 g/dl, p = 0.03). Children taking ART combined with iron supplements experienced a larger increase in Hb compared to those receiving neither ART nor iron supplements (mean Hb change 1.5 g/dl, p < 0.01). CONCLUSION:Anemia, particularly iron deficiency anemia and anemia of inflammation, is highly prevalent among children with HIV infection. Micronutrient supplements combined with ART improved anemia in HIV-infectedchildren.
Authors: S Muthayya; P Thankachan; M B Zimmermann; M Andersson; A Eilander; D Misquith; R F Hurrell; A V Kurpad Journal: Eur J Clin Nutr Date: 2007-01-24 Impact factor: 4.016
Authors: M Angeles Vázquez López; Francisco Lendinez Molinos; Moisés Leyva Carmona; Amparo Carracedo Morales; Francisco Javier Muñoz Vico; Juan López Muñoz; Antonio Muñoz Hoyos Journal: J Pediatr Hematol Oncol Date: 2006-12 Impact factor: 1.289
Authors: Y Salhi; D Costagliola; P Rebulla; C Dessi; M Karagiorga; D Lena-Russo; M de Montalembert; R Girot Journal: J Acquir Immune Defic Syndr Hum Retrovirol Date: 1998-08-15
Authors: Roland Kupka; Gernard I Msamanga; Ferdinand Mugusi; Paul Petraro; David J Hunter; Wafaie W Fawzi Journal: J Nutr Date: 2007-10 Impact factor: 4.798
Authors: Asha R Kallianpur; Quan Wang; Peilin Jia; Todd Hulgan; Zhongming Zhao; Scott L Letendre; Ronald J Ellis; Robert K Heaton; Donald R Franklin; Jill Barnholtz-Sloan; Ann C Collier; Christina M Marra; David B Clifford; Benjamin B Gelman; Justin C McArthur; Susan Morgello; David M Simpson; J A McCutchan; Igor Grant Journal: J Infect Dis Date: 2015-12-21 Impact factor: 5.226
Authors: Pagakrong Lumbiganon; Pope Kosalaraksa; Torsak Bunupuradah; David Boettiger; Vonthanak Saphonn; Khanh H Truong; Nia Kurniati; Rawiwan Hansudewechakul; Viet C Do; Tavitiya Sudjaritruk; Nagalingeswaran Kumarasamy; Nantakar Kongstan; Nik K N Yusoff; Lam V Nguyen; Dewi K Wati; Kamarul Razali; Annette H Sohn; Azar Kariminia Journal: Asian Biomed (Res Rev News) Date: 2016-06
Authors: Nicholas J Kassebaum; Rashmi Jasrasaria; Mohsen Naghavi; Sarah K Wulf; Nicole Johns; Rafael Lozano; Mathilda Regan; David Weatherall; David P Chou; Thomas P Eisele; Seth R Flaxman; Rachel L Pullan; Simon J Brooker; Christopher J L Murray Journal: Blood Date: 2013-12-02 Impact factor: 22.113
Authors: Devan Jaganath; A Sarah Walker; Francis Ssali; Victor Musiime; Francis Kiweewa; Cissy Kityo; Robert Salata; Peter Mugyenyi Journal: AIDS Res Hum Retroviruses Date: 2014-02-07 Impact factor: 2.205